Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (4,027)	$ (6,626)	$ (10,214)	$ (10,852)
Available for sale securities - net unrealized gain	12	126	1	0
Foreign currency translation adjustment	(10)	0	(22)	0
Total other comprehensive loss	2	126	(21)	0
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders	$ (4,025)	$ (6,500)	$ (10,235)	$ (10,852)